financetom
Business
financetom
/
Business
/
Russia's Sberbank reports profit rise to $4.3 billion in 1st quarter
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Russia's Sberbank reports profit rise to $4.3 billion in 1st quarter
Apr 26, 2024 12:29 AM

MOSCOW (Reuters) -Russia's dominant lender Sberbank on Friday reported an 11.3% rise in first-quarter net profit to 397.4 billion roubles ($4.32 billion), boosted by growth in deposits and its loan portfolio.

Sberbank made record profits of 1.5 trillion roubles in 2023, a more than five-fold increase on the previous year, as Russia's banking sector recovered from the impact of financial sanctions over Russia's actions in Ukraine.

The state-owned bank, which dominates Russia's banking sector with around 110 million retail clients, this week announced plans to make a record annual dividend payment of more than $8 billion.

Sberbank is majority-owned by the state and those dividends make a sizeable contribution to Russia's budget revenues, ultimately enabling the government to continue heavy spending, in particular on what it calls its "special military operation" in Ukraine.

"We are observing strong growth for the start of the year in retail clients' funds (2.4%), which forms a solid base for the development of the business in the future," CEO German Gref said in a statement.

The bank's return on equity dropped to 24.2% from 25% a year ago. Net interest income surged 24.4% to 700 billion roubles.

Sberbank's loan portfolio was up 1.1% year on year, driven largely by the consumer segment and clients' funds overall were 5.1% higher, spurred by corporate clients.

($1 = 91.9400 roubles)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Nike's Product Launches Could Drive Sales Turnaround, BofA Says
Nike's Product Launches Could Drive Sales Turnaround, BofA Says
Jun 21, 2024
11:35 AM EDT, 06/21/2024 (MT Newswires) -- Nike's ( NKE ) commitment to faster and more meaningful product launches could drive sales turnaround in the second half of fiscal 2025, BofA Securities said in a note to clients. We have seen green shoots on the innovation front as three of its major retailers...are energized by its new products, BofA said,...
Toyota Texas to Expand With $531 Million Investment
Toyota Texas to Expand With $531 Million Investment
Jun 21, 2024
11:34 AM EDT, 06/21/2024 (MT Newswires) -- Toyota Motor ( TM ) said Friday that Toyota Texas is expanding in the state with a new $531 million investment that will bring more than 400 new jobs to San Antonio. The investment will also bring a new onsite 500,000-square-foot facility that will be dedicated to the production of drivetrain parts, Toyota...
Update: Asana Shares Jump on Share Buyback Plan
Update: Asana Shares Jump on Share Buyback Plan
Jun 21, 2024
11:31 AM EDT, 06/21/2024 (MT Newswires) -- (Updates with share price movement in the headline and first paragraph, additional detail in second paragraph) Asana (ASAN) shares rose more than 9% in Friday trading after the company said its board has approved a buyback program of up to $150 million of its class A shares through June 30, 2025. The company...
Sarepta Therapeutics' Gets Label Expansion for Elevidys in 'Best-case Scenario,' BofA Securities Says
Sarepta Therapeutics' Gets Label Expansion for Elevidys in 'Best-case Scenario,' BofA Securities Says
Jun 21, 2024
11:38 AM EDT, 06/21/2024 (MT Newswires) -- Sarepta Therapeutics ( SRPT ) received label expansion from the US Food and Drug Administration for Elevidys to treat ambulatory Duchenne muscular dystrophy, marking a best-case scenario and exceeding expectations, BofA Securities said Thursday in a report. Sarepta said late Thursday the agency approved the label expansion to include patients ages 4 and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved